Who executed the Cadre Holdings (CDRE) share sales reported in the Form 4?

The sales were executed by Kanders SAF, LLC , an entity for which Warren B. Kanders is the sole manager and member. The transactions are reported as indirect holdings, not as direct personal trades, though he reports them subject to a beneficial ownership disclaimer.

[Form 4] Cadre Holdings, Inc. Insider Trading Activity

Q: What did Cadre Holdings (CDRE) disclose in this Form 4 filing?

Cadre Holdings reported that an entity associated with CEO Warren B. Kanders, Kanders SAF, LLC, sold Common Stock in open-market transactions. The filing details share amounts, weighted average prices, remaining holdings, and a disclaimer of beneficial ownership beyond his pecuniary interest.

Q: How many Cadre Holdings (CDRE) shares were sold and at what prices?

Kanders SAF, LLC sold 200,000 shares of Cadre Holdings Common Stock. It sold 100,000 shares at a weighted average price of $31.40 and another 100,000 shares at $31.93 , both executed in multiple trades within stated price ranges.

Q: What Cadre Holdings (CDRE) stake remains after these reported sales?

After the sales, Kanders SAF, LLC held 9,917,039 shares of Common Stock. Warren B. Kanders also reported 22,888 shares directly, 1,305,650 shares via his Roth IRA and 23,450 shares via his spouse’s Roth IRA, while disclaiming beneficial ownership beyond pecuniary interest.

Q: Do the Cadre Holdings (CDRE) footnotes mention a trading plan or special conditions?

The footnotes describe weighted average prices , price ranges for the multiple trades, Kanders’s role at Kanders SAF, LLC, his spouse’s relationship, and a beneficial ownership disclaimer. They do not reference any Rule 10b5-1 trading plan in the provided excerpt.

Filing Impact

(Very High)

Filing Sentiment

(Very Negative)

Form Type

Rhea-AI Filing Summary

Cadre Holdings, Inc. director, CEO and chairman Warren B. Kanders reported open-market sales of Common Stock through an affiliated entity. Kanders SAF, LLC sold 100,000 shares on March 20 at a weighted average price of $31.40 per share and another 100,000 shares on March 23 at a weighted average price of $31.93 per share, each executed across multiple trades within stated price ranges. After these sales, Kanders SAF, LLC held 9,917,039 shares, while Warren B. Kanders also reported 22,888 shares held directly, 1,305,650 shares held through his Roth IRA and 23,450 shares held through his spouse’s Roth IRA, and he disclaimed beneficial ownership beyond his pecuniary interest in these securities.

Insider Trade Summary

Net Seller: 200,000 shares ($6,333,000)

Net Sell 5 txns

Insider KANDERS WARREN B

Role CEO AND CHAIRMAN

Sold 200,000 shs ($6.33M)

Type	Security	Shares	Price	Value
Sale	Common Stock	100,000	$31.93	$3.19M
Sale	Common Stock, par value $0.0001 per share ("Common Stock")	100,000	$31.40	$3.14M
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 9,917,039 shares (Indirect, By Kanders SAF, LLC); Common Stock, par value $0.0001 per share ("Common Stock") — 10,017,039 shares (Indirect, By Kanders SAF, LLC); Common Stock — 22,888 shares (Direct)

Footnotes (1)

The price reported in Column 4 is a weighted average price per share. These shares of Common Stock were sold in multiple transactions at prices ranging from $31.01-$31.79 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of Common Stock sold at each separate price within the ranges set forth in this footnote (1) to this Form 4. The price reported in Column 4 is a weighted average price per share. These shares of Common Stock were sold in multiple transactions at prices ranging from $31.56-$32.49 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of Common Stock sold at each separate price within the ranges set forth in this footnote (2) to this Form 4. The Reporting Person is the sole manager and member of Kanders SAF, LLC. Allison Kanders is the Reporting Person's spouse. The Reporting Person disclaims beneficial ownership of the securities described in this statement, except to the extent of his pecuniary interest in such securities.

Form 4 Insider Transactions: What Each Field Means →

03/24/2026 - 04:15 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

KANDERS WARREN B

(Last)

(First)

(Middle)

C/O KANDERS & COMPANY, INC.

250 ROYAL PALM WAY, SUITE 201

(Street)

PALM BEACH

FLORIDA

33480

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Cadre Holdings, Inc. [ CDRE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
	CEO AND CHAIRMAN

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/20/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock, par value $0.0001 per share ("Common Stock")	03/20/2026		S		100,000	D	$31.4⁽¹⁾	10,017,039	I	By Kanders SAF, LLC⁽³⁾⁽⁵⁾
Common Stock	03/23/2026		S		100,000	D	$31.93⁽²⁾	9,917,039	I	By Kanders SAF, LLC⁽³⁾⁽⁵⁾
Common Stock								22,888	D
Common Stock								1,305,650	I	By Warren B. Kanders Roth IRA
Common Stock								23,450	I	By Allison Kanders Roth IRA⁽⁴⁾⁽⁵⁾

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. The price reported in Column 4 is a weighted average price per share. These shares of Common Stock were sold in multiple transactions at prices ranging from $31.01-$31.79 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of Common Stock sold at each separate price within the ranges set forth in this footnote (1) to this Form 4.

2. The price reported in Column 4 is a weighted average price per share. These shares of Common Stock were sold in multiple transactions at prices ranging from $31.56-$32.49 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of Common Stock sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.

3. The Reporting Person is the sole manager and member of Kanders SAF, LLC.

4. Allison Kanders is the Reporting Person's spouse.

5. The Reporting Person disclaims beneficial ownership of the securities described in this statement, except to the extent of his pecuniary interest in such securities.

	/s/ Warren B. Kanders	03/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did Cadre Holdings (CDRE) disclose in this Form 4 filing?

Cadre Holdings reported that an entity associated with CEO Warren B. Kanders, Kanders SAF, LLC, sold Common Stock in open-market transactions. The filing details share amounts, weighted average prices, remaining holdings, and a disclaimer of beneficial ownership beyond his pecuniary interest.

How many Cadre Holdings (CDRE) shares were sold and at what prices?

Kanders SAF, LLC sold 200,000 shares of Cadre Holdings Common Stock. It sold 100,000 shares at a weighted average price of $31.40 and another 100,000 shares at $31.93, both executed in multiple trades within stated price ranges.

What Cadre Holdings (CDRE) stake remains after these reported sales?

After the sales, Kanders SAF, LLC held 9,917,039 shares of Common Stock. Warren B. Kanders also reported 22,888 shares directly, 1,305,650 shares via his Roth IRA and 23,450 shares via his spouse’s Roth IRA, while disclaiming beneficial ownership beyond pecuniary interest.

Were the Cadre Holdings (CDRE) insider transactions open-market trades?

Yes. Both transactions are coded S as non-derivative open-market sales of Common Stock. Footnotes state the reported prices are weighted averages for multiple trades executed within specified price ranges, typical of open-market transaction reporting.

Do the Cadre Holdings (CDRE) footnotes mention a trading plan or special conditions?

The footnotes describe weighted average prices, price ranges for the multiple trades, Kanders’s role at Kanders SAF, LLC, his spouse’s relationship, and a beneficial ownership disclaimer. They do not reference any Rule 10b5-1 trading plan in the provided excerpt.